Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$62.53
-1.43-2.24%
al cierre: Nov 14, 4:00 PM EST
$62.53
N/A
Pre-comercialización: 4:06 AM EST
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
ArcBest Corp tiene un precio objetivo de consenso de $108.25 basado en las calificaciones de 17 analistas. El máximo es $205, emitido por Stephens & Co. el febrero 7, 2024. El mínimo es $74, emitido por Wells Fargo el noviembre 6, 2025. Las 3 calificaciones de analistas más recientes fueron publicadas por UBS, Wells Fargo y Stifel el noviembre 6, 2025, noviembre 6, 2025 y octubre 28, 2025, respectivamente. Con un precio objetivo promedio de $78.67 entre UBS, Wells Fargo y Stifel, hay una 25.81% upside implícita para ArcBest Corp según estas calificaciones más recientes de analistas.
Firmas de analistas que realizan recomendaciones1
UBS
Wells Fargo
Stifel
JP Morgan
Citigroup
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para ArcBest
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/06/2025 | 23.14% | UBS | $80 → $77 | Maintains | Neutral | |||
11/06/2025 | 18.34% | Wells Fargo | $80 → $74 | Maintains | Equal-Weight | |||
10/28/2025 | 35.93% | Stifel | $81 → $85 | Maintains | Buy | |||
10/08/2025 | 39.13% | JP Morgan | $85 → $87 | Maintains | Neutral | |||
10/08/2025 | 42.33% | Citigroup | $79 → $89 | Upgrade | Neutral → Buy | |||
09/30/2025 | 27.94% | UBS | $73 → $80 | Maintains | Neutral | |||
09/10/2025 | 26.34% | Citigroup | $83 → $79 | Maintains | Neutral | |||
07/31/2025 | 27.94% | Wells Fargo | $90 → $80 | Maintains | Equal-Weight | |||
07/31/2025 | 29.54% | Stifel | $93 → $81 | Maintains | Buy | |||
07/31/2025 | 107.9% | Morgan Stanley | $140 → $130 | Maintains | Overweight | |||
07/31/2025 | 16.74% | UBS | $84 → $73 | Maintains | Neutral | |||
07/24/2025 | 48.73% | Stifel | $83 → $93 | Maintains | Buy | |||
07/09/2025 | 42.33% | Citigroup | $67 → $89 | Maintains | Neutral | |||
07/08/2025 | 42.33% | JP Morgan | $75 → $89 | Maintains | Neutral | |||
07/08/2025 | 34.34% | UBS | $64 → $84 | Maintains | Neutral | |||
07/07/2025 | 43.93% | Wells Fargo | $60 → $90 | Maintains | Equal-Weight | |||
06/11/2025 | 35.93% | Jefferies | $75 → $85 | Maintains | Buy | |||
06/10/2025 | 18.34% | B of A Securities | $63 → $74 | Upgrade | Underperform → Neutral | |||
06/09/2025 | 0.75% | B of A Securities | $67 → $63 | Maintains | Underperform | |||
06/02/2025 | 61.52% | Goldman Sachs | $84 → $101 | Upgrade | Neutral → Buy | |||
05/16/2025 | 7.15% | B of A Securities | $58 → $67 | Maintains | Underperform | |||
04/30/2025 | 34.34% | Goldman Sachs | $97 → $84 | Maintains | Neutral | |||
04/30/2025 | 32.74% | Stifel | $102 → $83 | Maintains | Buy | |||
04/30/2025 | -4.05% | Wells Fargo | $80 → $60 | Maintains | Equal-Weight | |||
04/30/2025 | 2.35% | UBS | $100 → $64 | Maintains | Neutral | |||
04/24/2025 | 43.93% | Truist Securities | $93 → $90 | Maintains | Buy | |||
04/10/2025 | 55.13% | Goldman Sachs | $108 → $97 | Maintains | Neutral | |||
04/09/2025 | 51.93% | Jefferies | $120 → $95 | Maintains | Buy | |||
04/08/2025 | 5.55% | Citigroup | $83 → $66 | Maintains | Neutral | |||
03/27/2025 | 27.94% | Wells Fargo | $96 → $80 | Maintains | Equal-Weight | |||
03/14/2025 | 72.72% | Goldman Sachs | $126 → $108 | Maintains | Neutral | |||
03/13/2025 | 48.73% | Truist Securities | → $93 | Initiates | → Buy | |||
03/12/2025 | 16.74% | B of A Securities | $100 → $73 | Maintains | Underperform | |||
03/11/2025 | 32.74% | Citigroup | $103 → $83 | Maintains | Neutral | |||
03/11/2025 | 85.51% | Stephens & Co. | $116 → $116 | Reiterates | Overweight → Overweight | |||
02/03/2025 | 59.92% | UBS | $110 → $100 | Maintains | Neutral | |||
02/03/2025 | 53.53% | Wells Fargo | $105 → $96 | Maintains | Equal-Weight | |||
02/03/2025 | 131.89% | Morgan Stanley | $160 → $145 | Maintains | Overweight | |||
01/23/2025 | 99.9% | Stifel | $109 → $125 | Maintains | Buy | |||
01/15/2025 | 74.32% | Stifel | $114 → $109 | Maintains | Buy | |||
01/07/2025 | 67.92% | Wells Fargo | $115 → $105 | Maintains | Equal-Weight | |||
11/12/2024 | 103.1% | Citigroup | $110 → $127 | Maintains | Neutral | |||
11/04/2024 | 75.92% | UBS | $111 → $110 | Maintains | Neutral | |||
11/04/2024 | 87.11% | JP Morgan | $130 → $117 | Maintains | Neutral | |||
11/04/2024 | 67.92% | Wells Fargo | $112 → $105 | Maintains | Equal-Weight | |||
11/04/2024 | 171.87% | Morgan Stanley | $175 → $170 | Maintains | Overweight | |||
10/21/2024 | 90.31% | Stifel | $131 → $119 | Maintains | Buy | |||
10/14/2024 | 82.31% | TD Cowen | $131 → $114 | Downgrade | Buy → Hold | |||
10/10/2024 | 107.9% | Jefferies | $140 → $130 | Maintains | Buy | |||
10/09/2024 | 99.9% | Goldman Sachs | $133 → $125 | Maintains | Neutral | |||
10/09/2024 | — | Wolfe Research | — | Downgrade | Outperform → Peer Perform | |||
10/09/2024 | 77.51% | Citigroup | → $111 | Initiates | → Neutral | |||
09/06/2024 | 112.7% | JP Morgan | $134 → $133 | Maintains | Neutral | |||
09/05/2024 | 109.5% | TD Cowen | $136 → $131 | Maintains | Buy | |||
09/04/2024 | 107.9% | Stephens & Co. | $130 → $130 | Reiterates | Overweight → Overweight | |||
09/04/2024 | 79.11% | Wells Fargo | $122 → $112 | Downgrade | Overweight → Equal-Weight | |||
09/04/2024 | 58.32% | B of A Securities | $102 → $99 | Maintains | Underperform | |||
08/06/2024 | 109.5% | Stifel | $150 → $131 | Maintains | Buy | |||
08/05/2024 | 117.5% | TD Cowen | $148 → $136 | Maintains | Buy | |||
08/05/2024 | 114.3% | JP Morgan | $127 → $134 | Maintains | Neutral | |||
07/22/2024 | 79.11% | B of A Securities | $110 → $112 | Maintains | Underperform | |||
07/09/2024 | 103.1% | JP Morgan | $145 → $127 | Downgrade | Overweight → Neutral | |||
07/08/2024 | 181.46% | Morgan Stanley | $180 → $176 | Maintains | Overweight | |||
06/07/2024 | 123.89% | Wells Fargo | → $140 | Initiates | → Overweight | |||
05/15/2024 | 139.88% | Stifel | $159 → $150 | Maintains | Buy | |||
05/01/2024 | 136.69% | TD Cowen | $177 → $148 | Maintains | Buy | |||
05/01/2024 | 75.92% | B of A Securities | $143 → $110 | Maintains | Underperform | |||
05/01/2024 | 101.5% | UBS | $150 → $126 | Maintains | Neutral | |||
05/01/2024 | 131.89% | JP Morgan | $164 → $145 | Maintains | Overweight | |||
04/15/2024 | 128.69% | B of A Securities | $141 → $143 | Maintains | Underperform | |||
04/11/2024 | 138.29% | Goldman Sachs | $133 → $149 | Maintains | Neutral | |||
04/09/2024 | 162.27% | JP Morgan | $168 → $164 | Maintains | Overweight | |||
03/11/2024 | 168.67% | JP Morgan | → $168 | Initiates | → Overweight | |||
02/16/2024 | 139.88% | UBS | $119 → $150 | Maintains | Neutral | |||
02/07/2024 | 179.87% | Morgan Stanley | $155 → $175 | Maintains | Overweight | |||
02/07/2024 | 154.28% | Stifel | $153 → $159 | Maintains | Buy | |||
02/07/2024 | 227.84% | Stephens & Co. | $165 → $205 | Maintains | Overweight | |||
01/29/2024 | 136.69% | Deutsche Bank | → $148 | Initiates | → Buy | |||
01/10/2024 | 144.68% | Stifel | $136 → $153 | Maintains | Buy | |||
11/02/2023 | 90.31% | UBS | $110 → $119 | Maintains | Neutral | |||
10/30/2023 | 117.5% | Stifel | $132 → $136 | Maintains | Buy | |||
10/30/2023 | 131.89% | Morgan Stanley | $135 → $145 | Maintains | Overweight | |||
10/09/2023 | 72.72% | B of A Securities | $110 → $108 | Maintains | Underperform | |||
10/04/2023 | 107.9% | Citigroup | $137 → $130 | Maintains | Buy | |||
09/18/2023 | 75.92% | UBS | → $110 | Initiates | → Neutral | |||
08/21/2023 | — | Wolfe Research | — | Upgrade | Peer Perform → Outperform | |||
08/01/2023 | 115.9% | Morgan Stanley | $125 → $135 | Maintains | Overweight | |||
08/01/2023 | 114.3% | Stifel | $125 → $134 | Maintains | Buy | |||
07/31/2023 | 119.09% | Citigroup | $118 → $137 | Maintains | Buy | |||
07/31/2023 | 115.9% | Morgan Stanley | $125 → $135 | Maintains | Overweight | |||
07/31/2023 | 87.11% | Goldman Sachs | $105 → $117 | Maintains | Neutral | |||
07/31/2023 | 103.1% | Credit Suisse | $104 → $127 | Downgrade | Outperform → Neutral | |||
07/06/2023 | 99.9% | Morgan Stanley | $136 → $125 | Maintains | Overweight | |||
06/30/2023 | 88.71% | Citigroup | $110 → $118 | Maintains | Buy | |||
06/13/2023 | 72.72% | TD Cowen | $119 → $108 | Maintains | Outperform | |||
06/12/2023 | 75.92% | Jefferies | → $110 | Initiates | → Buy | |||
05/01/2023 | 80.71% | Stifel | $114 → $113 | Maintains | Buy | |||
05/01/2023 | 72.72% | Credit Suisse | → $108 | Reiterates | → Outperform | |||
05/01/2023 | 45.53% | B of A Securities | $101 → $91 | Downgrade | Neutral → Underperform | |||
04/04/2023 | 117.5% | Morgan Stanley | $138 → $136 | Maintains | Overweight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de ArcBest (ARCB)?
El último precio objetivo de ArcBest (NASDAQ:ARCB) fue comunicado por UBS el noviembre 6, 2025. La firma de analistas fijó un precio objetivo para $77.00 que espera ARCB a rise dentro de 12 meses (un posible 23.14% upside). 41 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre ArcBest (ARCB)?
La última calificación de analistas para ArcBest (NASDAQ:ARCB) fue proporcionada por UBS, y ArcBest mantuvo su neutral calificación.
¿Cuándo se produjo la última revisión al alza de ArcBest (ARCB)?
La última revisión al alza de ArcBest Corp se produjo en octubre 8, 2025, cuando Citigroup elevó su precio objetivo a $89. Citigroup anteriormente tenía a neutral para ArcBest Corp.
¿Cuándo fue la última revisión a la baja de ArcBest (ARCB)?
La última revisión a la baja de ArcBest Corp se produjo en octubre 14, 2024, cuando TD Cowen cambió su precio objetivo de $131 a $114 para ArcBest Corp.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para ArcBest (ARCB)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de ArcBest, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de ArcBest se registró el noviembre 6, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 6, 2026.
¿Es correcta la calificación de los analistas sobre ArcBest (ARCB)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de ArcBest (ARCB) fue un mantuvo con un precio objetivo de $80.00 a $77.00. El precio actual al que cotiza ArcBest (ARCB) es de $62.53, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.